Search results
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 5 days agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
NBC Philadelphia· 5 days agoModerna posted a narrower-than-expected loss for the first quarter as the company's cost-cutting...
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Benzinga via Yahoo Finance· 5 days agoMerck reported improvement in cancer patients receiving its Keytruda regimen. Enrolling 698...
Moderna stock surges 15% after it beat earnings expectations despite plummeting COVID vaccine sales
Quartz· 5 days agoModerna stock soared on Thursday after its first-quarter earnings report sailed past Wall Street’s...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
AOL· 5 days agoThe dark days of the pandemic are finally in the past for most of us—and that seems to be reflected in the earnings for Moderna, whose revenue is dependent on sales of its ...
Unveiling Moderna (MRNA)'s Value: Is It Really Priced Right? A C
Guru Focus· 1 day agoPer Share standing at 15.67, this analysis seeks to delve deep into Moderna's valuation, encouraging investors to scrutinize the following insights. Moderna
What to know about the new 'FLiRT' COVID variants that are spreading: Your guide to the latest virus...
Yahoo Life· 1 day agoHere’s your go-to guide with everything you need to know about COVID-19, including the latest...
Moderna quarterly sales beat expectations but plummet from previous year
Reuters via AOL· 5 days ago(Reuters) -Moderna on Thursday reported quarterly revenue that beat Wall Street estimates but came...
Moderna posts quarterly sales beat, smaller loss than expected
Reuters via Yahoo Finance· 5 days ago(Reuters) -Moderna on Thursday reported quarterly revenue that beat Wall Street estimates but came...
Moderna Inc (MRNA)'s Uncertain Future: Understanding the Barrier
Guru Focus· 1 day agoLong-established in the Biotechnology industry, Moderna Inc (MRNA, Financial) has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, growth ...